Cancer medicines

Ribociclib

Ribociclib

A CDK4/6 inhibitor paired with endocrine therapy in selected early or advanced breast cancers.

Sources checked · Introductory guide

On this page

How it works

It inhibits CDK4 and CDK6 to slow cancer cell division.[3]

Where it is used

Used with endocrine therapy in HR-positive, HER2-negative breast cancer according to stage, recurrence risk and prior therapy.[1]

Key safety points

Confirm ECG, electrolytes, blood counts and liver tests. Report fainting, palpitations, fever or jaundice immediately.[2]

Questions for your care team

  • How are heart rhythm, interactions, tests and treatment breaks managed?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Ribociclib Succinate (opens in a new tab)
  2. MedlinePlus · Ribociclib Succinate (opens in a new tab)
  3. NCI Drug Dictionary · Ribociclib Succinate (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Ribociclib | Cancer Encyclopedia | My Chemo Diary